Match each clinical presentation and diagnostic finding to the most appropriate next step in management or definitive treatment.
- A 44-year-old woman presents with constant watery vaginal discharge 3 weeks following a difficult radical hysterectomy. A vaginal tampon is placed, and methylene blue is instilled into the bladder via a catheter; the tampon shows no blue discoloration. Subsequently, intravenous indigo carmine is administered, and the tampon turns blue.Placement of a ureteral stent
- A 72-year-old woman complains of urinary leakage with minimal exertion. Pelvic examination shows a well-supported anterior vaginal wall with an angle of straining of 15 degrees on a cotton swab test. Urodynamic testing demonstrates a Valsalva leak point pressure of 45 cm H2O.Transurethral injection of bulking agents
- A 68-year-old woman with long-standing, poorly controlled type 2 diabetes mellitus presents with constant urinary dribbling. Urodynamic studies show a postvoid residual volume of 550 mL and an absence of detrusor contractions during the voiding phase.Initiation of intermittent clean self-catheterization
- A 38-year-old woman complains of dyspareunia, recurrent cystitis, and involuntary loss of urine occurring shortly after she finishes voiding. Pelvic examination reveals a tender, fluctuant mass in the anterior vaginal wall that produces purulent urethral discharge upon compression.Transvaginal diverticulectomy
- A 65-year-old woman presents with frequent, sudden, and overwhelming needs to void, resulting in large-volume leakage. Urodynamic testing reveals spontaneous, uninhibited detrusor contractions at a bladder volume of 150 mL, with a normal postvoid residual.Initiation of an antimuscarinic agent or beta-3 adrenergic agonist
Answer
The scenarios match their respective treatments based on distinct pathophysiologic mechanisms: ureterovaginal fistula requires ureteral stenting; intrinsic sphincter deficiency with a fixed urethra requires urethral bulking agents; diabetic neurogenic bladder requires intermittent self-catheterization; urethral diverticulum requires transvaginal diverticulectomy; and detrusor overactivity requires antimuscarinics or beta-3 agonists.
Each clinical vignette provides pathognomonic diagnostic findings for a distinct urogynecologic condition, which dictates a highly specific targeted therapy according to current urogynecology guidelines.
Step-by-Step Solution
Key Concept
Diagnosis and step-wise management of complex pelvic floor disorders including fistulas, intrinsic sphincter deficiency, neurogenic bladder, urethral diverticula, and detrusor overactivity.